Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-01-17 00:00:00 ET · period of report 2023-01-13 · accession 0001127602-23-001485 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-17 | 2023-01-13 | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.77 | -157.6K | 16.32M | -1.0% | -$279.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-01-13 | S | D | 157,627 | $1.77 | 16,324,314 | D | — | — |